The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Choosing Wisely’s Treatments,Tests that Pediatric Rheumatologists and Patients Should Question

Choosing Wisely’s Treatments,Tests that Pediatric Rheumatologists and Patients Should Question

November 1, 2013 • By Kurt Ullman

  • Tweet
  • Email
Print-Friendly Version / Save PDF

“After looking over the results, we settled on 10 items that were designated for an in-depth literature review,” says Dr. Ardoin. “From this, five were sent to the ACR board of directors for their input and approval. At their suggestion, two of the five were combined and another highly ranked item was added.”

You Might Also Like
  • The ACR Participates in Workgroup to Aid Transition of Pediatric Patients to Adult Healthcare Settings
  • New Toolkits Ease Pediatric-to-Adult-Care Transitions for Rheumatology Patients
  • Some Lupus Tests Yield False Results
Explore This Issue
November 2013
Also By This Author
  • New Toolkits Ease Pediatric-to-Adult-Care Transitions for Rheumatology Patients

The ACR’s Top Five list for pediatric rheumatologists as part of the ABIM Foundation’s Choosing Wisely campaign is:

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

1. Don’t order autoantibody panels unless the patient has a positive antinuclear antibody test (ANA) and evidence of rheumatic disease.

“These panels are expensive and, where there are no indications in the history and physical of rheumatic disease, there is no evidence that they add to the management of the patient,” says Dr. Rouster-Stevens. “The high levels of false positives with this test might unnecessarily instill anxiety in the patient and family, as well as triggering another round of unneeded testing.”

2. Don’t test for Lyme disease as a cause of musculoskeletal symptoms without an exposure history and appropriate exam findings.

“Lyme disease has received a lot of press recently, so rheumatologists get a lot of pressure from patients to test for it,” notes Dr. Ardoin. “It is important that physicians only test when there are symptoms and exam findings suggestive of [Lyme disease]. This would not only avoid wasting money, but also overuse of antibiotics that can lead to increased bacterial resistance.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

3. Don’t routinely perform surveillance joint radiographs to monitor juvenile idiopathic arthritis (JIA) disease activity.

“Of all the Top Five suggestions, the data on this one was the toughest to sort through,” says Dr. Rouster-Stevens. “But when we looked in depth, there was really no evidence supporting the idea that [radiographs] improved outcomes. In addition to the costs, there were concerns voiced about radiation exposure that could be avoided.”

4. Don’t perform methotrexate toxicity labs more often than every 12 weeks on stable doses.

“Fortunately, in children with rheumatic conditions, the frequency of liver or other abnormal values during methotrexate use is very low,” says Dr. Ardoin. “When a child is on a stable dose, there is little reason to test more often, unless they are at higher risk related to concomitant medications or comorbid conditions. Less testing reduces not only costs, but also anxiety and pain for the child.”

5. Don’t repeat a confirmed positive ANA in patients with established JIA or systemic lupus erythematous (SLE).

“Once the ANA is positive, it very likely to remain positive,” notes Dr. Ardoin. “Current evidence doesn’t suggest that changes in ANA or titer over time reflect an individual patient’s disease activity or course. It is not useful, and very costly, to serially test ANA.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 | Single Page

Filed Under: Practice Management Tagged With: ABIM Foundation, AC&R, Choosing Wisely, Pediatric, testsIssue: November 2013

You Might Also Like:
  • The ACR Participates in Workgroup to Aid Transition of Pediatric Patients to Adult Healthcare Settings
  • New Toolkits Ease Pediatric-to-Adult-Care Transitions for Rheumatology Patients
  • Some Lupus Tests Yield False Results
  • Award Targets Critical Shortage of Pediatric Rheumatologists

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.